Stockscreener 앱 받기
1.28
0.00%
0.00
시간 외 거래:
1.29
0.01
+0.78%
전일 마감가:
$1.28
열려 있는:
$1.27
하루 거래량:
468.26K
Relative Volume:
0.91
시가총액:
$44.55M
수익:
$2.91M
순이익/손실:
$-220.40M
주가수익비율:
-0.3516
EPS:
-3.64
순현금흐름:
$-176.15M
1주 성능:
-5.88%
1개월 성능:
+9.40%
6개월 성능:
-25.15%
1년 성능:
-88.08%
1일 변동 폭
$1.2625
$1.29
1주일 범위
$1.26
$1.365
52주 변동 폭
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
명칭
Igm Biosciences Inc
전화
650-965-7873
주소
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.28 | 81.86M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-01-10 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-10-01 | 다운그레이드 | Truist | Buy → Hold |
| 2024-02-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | 재개 | Jefferies | Buy |
| 2022-10-17 | 개시 | JP Morgan | Neutral |
| 2022-08-29 | 개시 | BofA Securities | Buy |
| 2021-12-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-08-26 | 개시 | Morgan Stanley | Overweight |
| 2021-01-29 | 개시 | RBC Capital Mkts | Outperform |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-22 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-07-17 | 개시 | Robert W. Baird | Outperform |
| 2020-07-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-28 | 개시 | SunTrust | Buy |
| 2020-04-22 | 개시 | Wedbush | Outperform |
| 2019-10-14 | 개시 | Guggenheim | Buy |
| 2019-10-14 | 개시 | Jefferies | Buy |
| 2019-10-14 | 개시 | Piper Jaffray | Overweight |
| 2019-10-14 | 개시 | Stifel | Buy |
모두보기
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.9%Here's What Happened - MarketBeat
What analysts say about IGM Biosciences Inc. stockHigh-velocity capital appreciation - PrintWeekIndia
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
What drives IGM Biosciences Inc. stock priceConsistently exceptional gains - jammulinksnews.com
Is IGM Biosciences Inc. a good long term investmentFree Stock Market Real-Time Monitoring - jammulinksnews.com
IGM Biosciences Inc. Stock Analysis and ForecastSignificant capital appreciation - Jammu Links News
Fierce Biotech Layoff Tracker 2025: Sail shrinks crew again; Sarepta lays off 500 staffers - Fierce Biotech
IGM Biosciences (NASDAQ:IGMS) Trading Down 5.9% – Here’s Why - Defense World
Why IGM Biosciences Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Concentra Group (CON) to Acquire IGM Biosciences - MSN
What makes IGM Biosciences Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
How IGM Biosciences Inc. stock performs during market volatilityFree Access to Group - Newser
In Brief: Concentra Snaps Up Struggling IGM Biosciences In Latest Biotech Deal - insights.citeline.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP - The Malaysian Reserve
IGM Biosciences to be acquired by Concentra - The Pharma Letter
Regeneron bispecific approved for myeloma; Concentra to buy IGM - BioPharma Dive
Concentra to acquire IGM Biosciences for $1.247 per share plus CVR - Investing.com Nigeria
Concentra Biosciences, LLC agreed to acquire IGM Biosciences, Inc. for $76.3 million. - MarketScreener
IGM Biosciences Shares Surge on Takeover Agreement with Concentra - MSN
IGM Biosciences Gets Snapped Up In Concentra Deal - Finimize
IGM Biosciences stock soars after Concentra acquisition deal - Investing.com
IGM Biosciences Enters Definitive Merger Agreement with Concentra Biosciences for Acquisition - Nasdaq
IGM Biosciences stock soars after Concentra acquisition deal By Investing.com - Investing.com UK
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from Russell 3000 Index - MarketScreener
Igm biosciences CFO Tahir Misbah sells $1,825 in stock - Investing.com
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
IGM Biosciences price target lowered to $1 from $2 at Truist - Yahoo Finance
IGM Biosciences Faces Nasdaq Non-Compliance Notice - TipRanks
Truist Revises IGM Biosciences (IGMS) Price Target to $1 | IGMS Stock News - GuruFocus
Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating - MarketScreener
IGM Biosciences (NASDAQ:IGMS) Cut to "Sell" at Wall Street Zen - MarketBeat
Millennium Management LLC Sells 69,074 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
Two Sigma Investments LP Grows Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Igm Biosciences Inc (IGMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):